{"id":"https://openalex.org/W2652994729","doi":null,"title":"Does isoniazid increase the hepatotoxicity of the combination prothionamide-dapsone? Isoprodian Study Group.","display_name":"Does isoniazid increase the hepatotoxicity of the combination prothionamide-dapsone? Isoprodian Study Group.","publication_year":1992,"publication_date":"1992-12-01","ids":{"openalex":"https://openalex.org/W2652994729","mag":"2652994729","pmid":"https://pubmed.ncbi.nlm.nih.gov/1299708"},"language":"en","primary_location":{"id":"pmid:1299708","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1299708","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association","raw_type":"Clinical Trial"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"H. Franck","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I39804081","display_name":"Sorbonne Universit\u00e9","ror":"https://ror.org/02en5vm52","country_code":"FR","type":"education","lineage":["https://openalex.org/I39804081"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"H. Franck","raw_affiliation_strings":["Sorbonne Université"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sorbonne Université","institution_ids":["https://openalex.org/I39804081"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020212154","display_name":"Jacques H.E. Grosset","orcid":"https://orcid.org/0000-0003-4509-0778","observed_orcids":["https://orcid.org/0000-0003-4509-0778"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J Grosset","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109485381","display_name":"C. Hupin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I39804081","display_name":"Sorbonne Universit\u00e9","ror":"https://ror.org/02en5vm52","country_code":"FR","type":"education","lineage":["https://openalex.org/I39804081"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"C. Hupin","raw_affiliation_strings":["Sorbonne Université"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sorbonne Université","institution_ids":["https://openalex.org/I39804081"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109934398","display_name":"Derk L. Leiker","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I39804081","display_name":"Sorbonne Universit\u00e9","ror":"https://ror.org/02en5vm52","country_code":"FR","type":"education","lineage":["https://openalex.org/I39804081"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"D. L. LEIKER","raw_affiliation_strings":["Sorbonne Université"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sorbonne Université","institution_ids":["https://openalex.org/I39804081"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003275621","display_name":"Dileep N. Lobo","orcid":"https://orcid.org/0000-0003-1187-5796","observed_orcids":["https://orcid.org/0000-0003-1187-5796"]},"institutions":[{"id":"https://openalex.org/I39804081","display_name":"Sorbonne Universit\u00e9","ror":"https://ror.org/02en5vm52","country_code":"FR","type":"education","lineage":["https://openalex.org/I39804081"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Dileep N. Lobo","raw_affiliation_strings":["Sorbonne Université"],"raw_orcid":"https://orcid.org/0000-0003-1187-5796","affiliations":[{"raw_affiliation_string":"Sorbonne Université","institution_ids":["https://openalex.org/I39804081"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000208805","display_name":"J M Mehta","orcid":"https://orcid.org/0000-0001-9927-149X","observed_orcids":["https://orcid.org/0000-0001-9927-149X"]},"institutions":[{"id":"https://openalex.org/I39804081","display_name":"Sorbonne Universit\u00e9","ror":"https://ror.org/02en5vm52","country_code":"FR","type":"education","lineage":["https://openalex.org/I39804081"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"J M Mehta","raw_affiliation_strings":["Sorbonne Université"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sorbonne Université","institution_ids":["https://openalex.org/I39804081"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087074327","display_name":"L. N. N'Deli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I39804081","display_name":"Sorbonne Universit\u00e9","ror":"https://ror.org/02en5vm52","country_code":"FR","type":"education","lineage":["https://openalex.org/I39804081"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"L. N. N'Deli","raw_affiliation_strings":["Sorbonne Université"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sorbonne Université","institution_ids":["https://openalex.org/I39804081"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5061458828","display_name":"Richard Urbanczik","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I39804081","display_name":"Sorbonne Universit\u00e9","ror":"https://ror.org/02en5vm52","country_code":"FR","type":"education","lineage":["https://openalex.org/I39804081"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"R Urbanczik","raw_affiliation_strings":["Sorbonne Université"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sorbonne Université","institution_ids":["https://openalex.org/I39804081"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.3467,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.68018018,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"60","issue":"4","first_page":"536","last_page":"41"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12107","display_name":"Leprosy Research and Treatment","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12107","display_name":"Leprosy Research and Treatment","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":0.00279999990016222,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10823","display_name":"Research on Leishmaniasis Studies","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/isoniazid","display_name":"isoniazid","score":0.9980000257492065},{"id":"https://openalex.org/keywords/hepatotoxicity","display_name":"hepatotoxicity","score":0.8669999837875366},{"id":"https://openalex.org/keywords/prothionamide","display_name":"prothionamide","score":0.878000020980835},{"id":"https://openalex.org/keywords/dapsone","display_name":"dapsone","score":0.9990000128746033},{"id":"https://openalex.org/keywords/thioamides","display_name":"thioamides","score":0.7720000147819519},{"id":"https://openalex.org/keywords/multibacillary-leprosy","display_name":"multibacillary leprosy","score":0.9229999780654907},{"id":"https://openalex.org/keywords/rifampicin","display_name":"rifampicin","score":0.9020000100135803},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.656000018119812},{"id":"https://openalex.org/keywords/aminotransferases","display_name":"transaminases","score":0.8849999904632568},{"id":"https://openalex.org/keywords/body-weight","display_name":"body weight","score":0.6800000071525574},{"id":"https://openalex.org/keywords/age","display_name":"age","score":0.5950000286102295},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.6819999814033508}],"concepts":[{"id":"https://openalex.org/C2777640609","wikidata":"https://www.wikidata.org/wiki/Q422226","display_name":"Dapsone","level":2,"score":0.8977231979370117},{"id":"https://openalex.org/C2776967927","wikidata":"https://www.wikidata.org/wiki/Q423169","display_name":"Isoniazid","level":3,"score":0.8701710104942322},{"id":"https://openalex.org/C2780695269","wikidata":"https://www.wikidata.org/wiki/Q36956","display_name":"Leprosy","level":2,"score":0.8566555976867676},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6001576781272888},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.36936041712760925},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.3193763494491577},{"id":"https://openalex.org/C2781069245","wikidata":"https://www.wikidata.org/wiki/Q12204","display_name":"Tuberculosis","level":2,"score":0.24710863828659058},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.11993256211280823}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003622","descriptor_name":"Dapsone","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003622","descriptor_name":"Dapsone","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007538","descriptor_name":"Isoniazid","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007538","descriptor_name":"Isoniazid","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D007917","descriptor_name":"Leprostatic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D007917","descriptor_name":"Leprostatic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008111","descriptor_name":"Liver Function Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011515","descriptor_name":"Prothionamide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011515","descriptor_name":"Prothionamide","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D012293","descriptor_name":"Rifampin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D015440","descriptor_name":"Leprosy, Lepromatous","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015994","descriptor_name":"Incidence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D056486","descriptor_name":"Chemical and Drug Induced Liver Injury","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:1299708","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1299708","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association","raw_type":"Clinical Trial"},{"id":"mag:2652994729","doi":null,"is_oa":false,"landing_page_url":"https://jhu.pure.elsevier.com/en/publications/does-isoniazid-increase-the-hepatotoxicity-of-the-combination-pro-4","pdf_url":null,"source":{"id":"https://openalex.org/S2754172772","display_name":"International journal of leprosy","issn_l":"0020-7349","issn":["0020-7349","0148-916X","1544-581X"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["jufo-1"],"host_organization":"https://openalex.org/P4324168566","host_organization_name":"The International Leprosy Association","host_organization_lineage":["https://openalex.org/P4324168566"],"host_organization_lineage_names":["The International Leprosy Association"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"International journal of leprosy","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4300437346","https://openalex.org/W2401496313","https://openalex.org/W11032412","https://openalex.org/W4248681080","https://openalex.org/W2739179929","https://openalex.org/W2420920368","https://openalex.org/W2474803053","https://openalex.org/W2418837411","https://openalex.org/W2412967159","https://openalex.org/W2412864285"],"abstract_inverted_index":{"In":[0],"order":[1],"to":[2,11,148,193,202,247],"assess":[3],"the":[4,44,91,121,126,133,142,155,172,178,185,203,210,213,215,224,238,241,252,264,267],"potential":[5],"additive":[6],"liver":[7,98,145],"toxicity":[8,146,265],"of":[9,13,22,120,125,141,157,171,182,187,205,217,226,240,266],"isoniazid":[10,75],"that":[12,259],"a":[14,17,79],"thioamide-containing":[15,268],"treatment,":[16,150,183],"prospective,":[18],"randomized,":[19],"double-blind":[20],"trial":[21],"24":[23],"weeks'":[24],"duration":[25],"involving":[26],"772":[27],"adult":[28],"patients":[29,143,163],"was":[30,129,160,190,244],"conducted":[31],"in":[32,36,39,43,69,154],"four":[33],"leprosy":[34,50],"centers--two":[35],"India,":[37],"one":[38,42],"Madagascar,":[40],"and":[41,58,83,97,114,123,184,197,223],"Ivory":[45],"Coast.":[46],"Patients":[47],"with":[48,72,78,165,231],"multibacillary":[49],"were":[51,100,199],"given":[52],"daily":[53],"100":[54],"mg":[55,60,66,74],"dapsone":[56],"(DDS)":[57],"350":[59,73],"prothionamide":[61],"(PTH)":[62],"plus":[63],"monthly":[64],"600":[65],"rifampin":[67],"(RMP)":[68],"combination":[70],"either":[71],"(INH)":[76],"or":[77,136,166],"placebo.":[80],"After":[81],"clinical":[82],"laboratory":[84,108],"(including":[85],"HBs-Ag":[86],"testing)":[87],"examinations":[88],"on":[89],"admission,":[90],"side":[92,127,158,174,206,218,228,242],"effects":[93,128,159,175,207,219,229,243],"(especially":[94],"gastrointestinal":[95],"disturbances":[96],"toxicity)":[99],"assessed":[101],"at":[102],"regular":[103],"intervals":[104],"during":[105,177],"treatment":[106],"by":[107,115],"testing":[109],"(aminotransferases,":[110],"bilirubin,":[111],"alkaline":[112],"phosphatase)":[113],"recording":[116],"spontaneous":[117],"complaints.":[118],"Analysis":[119],"frequency":[122,204,239],"seriousness":[124],"made":[130],"before":[131],"breaking":[132],"code":[134],"(with":[135],"without":[137,167],"INH).":[138],"Although":[139],"10%":[140],"had":[144],"leading":[147],"stopping":[149],"no":[151],"significant":[152],"difference":[153],"occurrence":[156],"observed":[161,173],"between":[162],"treated":[164],"INH.":[168,194],"Most":[169],"(75%)":[170],"occurred":[176],"first":[179],"4":[180],"weeks":[181],"time":[186],"their":[188],"onset":[189],"not":[191,245,262],"related":[192,201,246],"Body":[195],"weight":[196],"age":[198,232],"factors":[200],"[the":[208],"higher":[209],"body":[211],"weight,":[212],"lesser":[214],"rate":[216,225],"(p":[220,233],"=":[221,234],"0.03)]":[222],"serious":[227],"increased":[230],"0.02).":[235],"But,":[236],"again,":[237],"INH":[248,260],"administration.":[249],"Therefore,":[250],"from":[251],"present":[253],"study":[254],"it":[255],"can":[256],"be":[257],"concluded":[258],"does":[261],"increase":[263],"treatment.":[269]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2017-06-30T00:00:00"}